Status:
RECRUITING
Investigation of the Effects of Pulmonary Rehabilitation in Children With Primary Immunodeficiency
Lead Sponsor:
Gazi University
Conditions:
Primary Immunodeficiency
Eligibility:
All Genders
6-18 years
Phase:
NA
Brief Summary
Primary immunodeficiencies (PID) are a heterogeneous group of diseases that occur as a result of disorders that affect the development, differentiation and/or function of various cells and building bl...
Detailed Description
Among the symptoms and complications of PID, pulmonary complications are very common and significantly increase the morbidity and mortality of the disease. Recurrent respiratory infections are often t...
Eligibility Criteria
Inclusion
- Patients aged 6-18 years with primary immunodeficiency
Exclusion
- Acute pulmonary exacerbation, acute upper or lower respiratory tract infection
- Serious neurological, neuromuscular, orthopedic and other systemic diseases or other diseases affecting physical functions
- Participating in a planned exercise program in the past three months
- Cognitive impairment, which may cause difficulty understanding and following exercise test instructions
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 20 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06092528
Start Date
November 1 2023
End Date
September 20 2026
Last Update
December 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gazi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Cardiopulmonary Rehabilitation Unit
Ankara, Çankaya, Turkey (Türkiye), 06490